First Manhattan CO Seelos Therapeutics, Inc. Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.59 - $1.04 $1,770 - $3,120	-3,000 Reduced 21.16%	11,175 $7,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $7,014 - $3.01 Million	-10,792 Reduced 43.23%	14,175 $14,000
Q2 2022 Aug 15, 2022	BUY	$0.51 - $0.93 $1,530 - $2,790	3,000 Added 13.66%	24,967 $16,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $25,858 - $61,904	9,795 Added 80.47%	21,967 $57,000
Q1 2021 May 14, 2021	BUY	$1.35 - $4.99 $16,432 - $60,738	12,172 New	12,172 $60,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.